Townson Sharon
- SEC CIK
- 0001855689
In the past year, 5 open-market sale filings worth $423.9K and no purchases.
Current role at each company
- GLUE Monte Rosa Therapeutics, Inc.Chief Scientific Officeras of Jul 7, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $423.9K
- 5 filings
- Net
- −$423.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Townson Sharon as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2026 (view filing)4:41 PM ET | Jul 6 | 1 day | Townson SharonChief Scientific Officer | SSale | −6.00K | $23.31 | −$139.8K | −8.1%67.8K after | 2 lots10b5-1 |
| Jun 25, 2026 (view filing) | Jun 23 | 2 days | Townson SharonChief Scientific Officer | SSale | −3.00K | $20.00 | −$60.0K | −4.2%67.8K after | 10b5-1 |
| Jun 18, 2026 (view filing) | Jun 17 | 1 day | Townson SharonChief Scientific Officer | SSale | −3.00K | $19.00 | −$57.0K | −4.2%67.8K after | 10b5-1 |
| Jun 1, 2026 (view filing) | May 29 | 3 days | Townson SharonChief Scientific Officer | SSale | −6.00K | $19.87 | −$119.2K | −8.1%67.8K after | 10b5-1 |
| Jan 5, 2026 (view filing) | Jan 5 | Same day | Townson SharonChief Scientific Officer | SSale | −3.15K | $15.17 | −$47.9K | −4.4%67.8K after |